Ontology highlight
ABSTRACT:
PROVIDER: EGAS00001001179 | EGA |
REPOSITORIES: EGA
van Thuijl Hinke F HF Mazor Tali T Johnson Brett E BE Fouse Shaun D SD Aihara Koki K Hong Chibo C Malmström Annika A Hallbeck Martin M Heimans Jan J JJ Kloezeman Jenneke J JJ Stenmark-Askmalm Marie M Lamfers Martine L M ML Saito Nobuhito N Aburatani Hiroyuki H Mukasa Akitake A Berger Mitchell S MS Söderkvist Peter P Taylor Barry S BS Molinaro Annette M AM Wesseling Pieter P Reijneveld Jaap C JC Chang Susan M SM Ylstra Bauke B Costello Joseph F JF
Acta neuropathologica 20150228 4
Temozolomide (TMZ) increases the overall survival of patients with glioblastoma (GBM), but its role in the clinical management of diffuse low-grade gliomas (LGG) is still being defined. DNA hypermethylation of the O (6) -methylguanine-DNA methyltransferase (MGMT) promoter is associated with an improved response to TMZ treatment, while inactivation of the DNA mismatch repair (MMR) pathway is associated with therapeutic resistance and TMZ-induced mutagenesis. We previously demonstrated that TMZ tr ...[more]